Henrik Endeman

13.9k citations

131 papers · 7.2k · 3 hit papers · h-index 27

Impact in

Internal Medicine top 0.2%
- Venous Thromboembolism Diagnosis and Management
Infectious Diseases top 0.1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research

Papers in

Epidemiology 61
- Pneumonia and Respiratory Infections 33
- Sepsis Diagnosis and Treatment 29
Critical Care and Intensive Care Medicine 37
- Intensive Care Unit Cognitive Disorders 20

Co-authors: Diederik Gommers (35 shared papers)Marieke J.H.A. Kruip (5 shared papers)Nardo J. M. van der Meer (6 shared papers)M. Sesmu Arbous (4 shared papers)Milou A.M. Stals (2 shared papers)Judith van Paassen (2 shared papers)Frederikus A. Klok (2 shared papers)Fleur H.J. Kaptein (2 shared papers)
Journals: Critical Care (12 papers)Journal of Critical Care (7 papers)Resuscitation (5 papers)Journal of Clinical Medicine (5 papers)Intensive Care Medicine Experimental (3 papers)
Partner nations: Netherlands United States Switzerland

In The Last Decade

Henrik Endeman

122 papers receiving 7.0k citations

Henrik Endeman's Hit Papers

align trajectories log scale

Phenotype and kinetics of SARS-CoV-2–specific T cells in COVID-19 patients with acute respiratory distress syndrome 2020 · 587 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 Science Immunology
2020 Thrombosis Research
2020 Thrombosis Research

Peers

Countries citing papers authored by Henrik Endeman

Since Specialization

Citations

This map shows the geographic impact of Henrik Endeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Endeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Endeman more than expected).

Fields of papers citing papers by Henrik Endeman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henrik Endeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Endeman. The network helps show where Henrik Endeman may publish in the future.

Co-authors

The 25 scholars most cited alongside Henrik Endeman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Henrik Endeman Line = papers co-authored together Henrik Endeman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 131 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Incidence of thrombotic complications in critically ill ICU patients with COVID-19 Thrombosis Research ·Frederikus A. Klok, Marieke J.H.A. Kruip, Nardo J. M. van der Meer, M. Sesmu Arbous, Diederik Gommers, K.M. Kant, Fleur H.J. Kaptein, Judith van Paassen, Milou A.M. Stals, Menno V. Huisman, Henrik Endeman Hit paper breakdown →	2020	3430
2	Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis Thrombosis Research ·Frederikus A. Klok, Marieke J.H.A. Kruip, Nardo J. M. van der Meer, M. Sesmu Arbous, Diederik Gommers, K.M. Kant, Fleur H.J. Kaptein, Judith van Paassen, Milou A.M. Stals, Menno V. Huisman, Henrik Endeman Hit paper breakdown →	2020	1089
3	Phenotype and kinetics of SARS-CoV-2–specific T cells in COVID-19 patients with acute respiratory distress syndrome Science Immunology ·Daniela Weiskopf, Katharina S. Schmitz, Matthijs P. Raadsen, Alba Grifoni, Nisreen M.A. Okba, Henrik Endeman, Johannes P. C. van den Akker, Richard Molenkamp, Marion Koopmans, Eric C. M. Van Gorp, Bart L. Haagmans, Rik L. de Swart, Alessandro Sette, Rory D. de Vries Hit paper breakdown →	2020	587
4	Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial The Lancet ·Sabine C A Meijvis, Hans A Hardeman, Hilde HF Remmelts, Rik Heijligenberg, Ger T. Rijkers, Heleen van Velzen‐Blad, G. Paul Voorn, E.M.W. van de Garde, Henrik Endeman, Jan C. Grutters, Willem Jan W. Bos, Douwe H. Biesma	2011	237
5	One-year survival after in-hospital cardiac arrest: A systematic review and meta-analysis Resuscitation ·Marc Schluep, Benjamin Gravesteijn, Robert Jan Stolker, Henrik Endeman, Sanne E. Hoeks	2018	127
6	Systemic cytokine response in patients with community-acquired pneumonia European Respiratory Journal ·Henrik Endeman, Sabine C A Meijvis, Ger T. Rijkers, Heleen van Velzen‐Blad, Coline H.M. van Moorsel, J.C. Grutters, Douwe H. Biesma	2010	98
7	Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT) Critical Care ·Alan Abdulla, Annemieke Dijkstra, Nicole Hunfeld, Henrik Endeman, Soma Bahmany, Tim M. J. Ewoldt, Anouk E. Muller, Teun van Gelder, Diederik Gommers, Birgit C. P. Koch	2020	90
8	The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial BMC Infectious Diseases ·Alan Abdulla, Tim M. J. Ewoldt, Nicole Hunfeld, Anouk E. Muller, Wim J. R. Rietdijk, Suzanne Polinder, Teun van Gelder, Henrik Endeman, Birgit C. P. Koch	2020	65
9	Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial Intensive Care Medicine ·Tim M. J. Ewoldt, Alan Abdulla, Wim J. R. Rietdijk, Anouk E. Muller, Brenda C. M. de Winter, Nicole Hunfeld, Ilse M. Purmer, Peter Van de Vliet, Evert‐Jan Wils, Jasper J. Haringman, Annelies Draisma, Tom A. Rijpstra, Attila Karakus, Diederik Gommers, Henrik Endeman, Birgit C. P. Koch	2022	60
10	Electrical Impedance Tomography for Positive End-Expiratory Pressure Titration in COVID-19–related Acute Respiratory Distress Syndrome American Journal of Respiratory and Critical Care Medicine ·Philip van der Zee, Peter Somhorst, Henrik Endeman, Diederik Gommers	2020	58
11	High Levels of Neutrophil Extracellular Traps Persist in the Lower Respiratory Tract of Critically Ill Patients With Coronavirus Disease 2019 The Journal of Infectious Diseases ·Werner J. D. Ouwendijk, Matthijs P. Raadsen, Jeroen J. A. van Kampen, Robert M. Verdijk, Jan H. von der Thüsen, Lihui Guo, Rogier A.S. Hoek, Johannes P. C. van den Akker, Henrik Endeman, Thomas Langerak, Richard Molenkamp, Diederik Gommers, Marion Koopmans, Eric C. M. Van Gorp, Georges M. G. M. Verjans, Bart L. Haagmans	2021	49
12	Long-term treated intensive care patients outcomes: the one-year mortality rate, quality of life, health care use and long-term complications as reported by general practitioners BMC Anesthesiology ·Simone Steenbergen, Saskia Rijkenberg, Tamara Adonis, Gerda Kroeze, Ilse van Stijn, Henrik Endeman	2015	47
13	Mannose-Binding Lectin Genotypes in Susceptibility to Community-Acquired Pneumonia CHEST Journal ·Henrik Endeman, Bjorn L. Herpers, B.A.W. de Jong, G. Paul Voorn, Jan C. Grutters, Heleen van Velzen‐Blad, Douwe H. Biesma	2008	42
14	Acute-phase responsiveness of mannose-binding lectin in community-acquired pneumonia is highly dependent uponMBL2genotypes Clinical & Experimental Immunology ·Bjorn L. Herpers, Henrik Endeman, B.A.W. de Jong, B. M. de Jongh, Jan C. Grutters, Douwe H. Biesma, Heleen van Velzen‐Blad	2009	42
15	Capillary Leukocytes, Microaggregates, and the Response to Hypoxemia in the Microcirculation of Coronavirus Disease 2019 Patients Critical Care Medicine ·Emanuele Favaron, Can İnce, Matthias P. Hilty, Bülent Ergin, Philip van der Zee, Zühre Uz, Pedro David Wendel‐Garcia, Daniel A. Hofmaenner, Claudio Acevedo, Wim Jan van Boven, Şakir Akın, Diederik Gommers, Henrik Endeman	2021	41
16	A systematic review of biomarkers multivariately associated with acute respiratory distress syndrome development and mortality Critical Care ·Philip van der Zee, Wim J. R. Rietdijk, Peter Somhorst, Henrik Endeman, Diederik Gommers	2020	40
17	Seasonal coronavirus–specific B cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19 Journal of Clinical Investigation ·Muriel Aguilar-Bretones, Brenda M. Westerhuis, Matthijs P. Raadsen, Erwin de Bruin, Felicity Chandler, Nisreen M.A. Okba, Bart L. Haagmans, Thomas Langerak, Henrik Endeman, Johannes P. C. van den Akker, Diederik Gommers, Eric C. M. Van Gorp, Corine H. GeurtsvanKessel, Rory D. de Vries, Ron A. M. Fouchier, Barry Rockx, Marion Koopmans, Gijsbert P. van Nierop	2021	38
18	The Fcγ Receptor IIA-R/R131 Genotype Is Associated with Severe Sepsis in Community-Acquired Pneumonia Clinical and Vaccine Immunology ·Henrik Endeman, Marie Claire A. Cornips, Jan C. Grutters, Jules M. van den Bosch, Hendrik J.T. Ruven, Heleen van Velzen‐Blad, Ger T. Rijkers, Douwe H. Biesma	2009	38
19	High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department BMC Infectious Diseases ·Kirby Tong‐Minh, Yuri van der Does, Susanna Engelen, Evelien de Jong, Christian Ramakers, Diederik Gommers, Eric C. M. Van Gorp, Henrik Endeman	2022	35
20	Myeloid-related protein-8/14 facilitates bacterial growth during pneumococcal pneumonia Thorax ·Ahmed Achouiti, Thomas Vogl, Henrik Endeman, Brittany L. Mortensen, Pierre‐François Laterre, Xavier Wittebole, Marieke A. D. van Zoelen, Yaofang Zhang, Jacobien J. Hoogerwerf, Sandrine Florquin, Marcus J. Schultz, Jan C. Grutters, Douwe H. Biesma, Johannes Roth, Eric P. Skaar, Cornelis van ′t Veer, Alex F. de Vos, Tom van der Poll	2014	33

About Henrik Endeman

Henrik Endeman is a scholar working on Epidemiology, Critical Care and Intensive Care Medicine, Pulmonary and Respiratory Medicine, Infectious Diseases and Pharmacology, having authored 131 papers that have together received 7.2k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (33 papers), Sepsis Diagnosis and Treatment (29 papers), Respiratory Support and Mechanisms (27 papers), COVID-19 Clinical Research Studies (27 papers), Antibiotics Pharmacokinetics and Efficacy (25 papers), Intensive Care Unit Cognitive Disorders (20 papers), Cardiac Arrest and Resuscitation (16 papers) and Long-Term Effects of COVID-19 (14 papers). The work is most often cited by research in Internal Medicine (1.1k citations), Infectious Diseases (4.4k citations), Neurology (2.3k citations), Critical Care and Intensive Care Medicine (608 citations) and Applied Microbiology and Biotechnology (137 citations). Henrik Endeman has collaborated with scholars based in Netherlands, United States and Switzerland. Frequent co-authors include Diederik Gommers, Marieke J.H.A. Kruip, Nardo J. M. van der Meer, M. Sesmu Arbous, Milou A.M. Stals, Judith van Paassen, Frederikus A. Klok, Fleur H.J. Kaptein, Menno V. Huisman and K.M. Kant. Their work appears in journals such as Critical Care, Journal of Critical Care, Resuscitation, Journal of Clinical Medicine and Intensive Care Medicine Experimental.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Henrik Endeman

Impact in

Papers in i

In The Last Decade

Henrik Endeman

Henrik Endeman's Hit Papers

Peers

Countries citing papers authored by Henrik Endeman

Fields of papers citing papers by Henrik Endeman

All Works

About Henrik Endeman

Explore authors with similar magnitude of impact

Papers in